Pathologic changes in upper respiratory passages and lungs following use of antibiotic electroaerosols.
D000336:Aerosols / Q000633:toxicity*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D007830:Larynx / Q000187:drug effects* / Q000473:pathology*; D008168:Lung / Q000187:drug effects* / Q000473:pathology*; D051379:Mice; D009666:Nose / Q000473:pathology; D010406:Penicillins / Q000633:toxicity; D051381:Rats; D013307:Streptomycin / Q000633:toxicity; D013752:Tetracycline / Q000633:toxicity; D014132:Trachea / Q000187:drug effects* / Q000473:pathology*
D000336:Aerosols; D000900:Anti-Bacterial Agents; D010406:Penicillins; D013752:Tetracycline; D013307:Streptomycin